Free Trial
NASDAQ:WVE

WAVE Life Sciences (WVE) Stock Price, News & Analysis

WAVE Life Sciences logo
$7.95 +0.25 (+3.25%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$7.78 -0.17 (-2.08%)
As of 07:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About WAVE Life Sciences Stock (NASDAQ:WVE)

Key Stats

Today's Range
$7.56
$8.13
50-Day Range
$5.94
$8.10
52-Week Range
$5.04
$16.74
Volume
2.57 million shs
Average Volume
1.29 million shs
Market Capitalization
$1.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.50
Consensus Rating
Moderate Buy

Company Overview

WAVE Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
89th Percentile Overall Score

WVE MarketRank™: 

WAVE Life Sciences scored higher than 89% of companies evaluated by MarketBeat, and ranked 122nd out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    WAVE Life Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    WAVE Life Sciences has only been the subject of 3 research reports in the past 90 days.

  • Read more about WAVE Life Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for WAVE Life Sciences are expected to grow in the coming year, from ($1.14) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of WAVE Life Sciences is -9.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of WAVE Life Sciences is -9.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    WAVE Life Sciences has a P/B Ratio of 5.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about WAVE Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    13.49% of the float of WAVE Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    WAVE Life Sciences has a short interest ratio ("days to cover") of 10.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in WAVE Life Sciences has recently decreased by 1.00%, indicating that investor sentiment is improving.
  • Dividend Yield

    WAVE Life Sciences does not currently pay a dividend.

  • Dividend Growth

    WAVE Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.49% of the float of WAVE Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    WAVE Life Sciences has a short interest ratio ("days to cover") of 10.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in WAVE Life Sciences has recently decreased by 1.00%, indicating that investor sentiment is improving.
  • News Sentiment

    WAVE Life Sciences has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for WAVE Life Sciences this week, compared to 6 articles on an average week.
  • Search Interest

    3 people have searched for WVE on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added WAVE Life Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, WAVE Life Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $208,500.00 in company stock.

  • Percentage Held by Insiders

    23.98% of the stock of WAVE Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    89.73% of the stock of WAVE Life Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about WAVE Life Sciences' insider trading history.
Receive WVE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WAVE Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

WVE Stock News Headlines

Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
Brokerages Set WAVE Life Sciences Ltd. (NASDAQ:WVE) PT at $20.50
Wave Life Sciences: Speculative, But Promising
Wave Life Sciences Ltd. (WVE) - Yahoo Finance
See More Headlines

WVE Stock Analysis - Frequently Asked Questions

WAVE Life Sciences' stock was trading at $12.37 on January 1st, 2025. Since then, WVE shares have decreased by 35.7% and is now trading at $7.95.

WAVE Life Sciences Ltd. (NASDAQ:WVE) announced its quarterly earnings data on Thursday, May, 8th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.27) by $0.02. The business had revenue of $9.18 million for the quarter, compared to analysts' expectations of $11.65 million.
Read the conference call transcript
.

Shares of WVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that WAVE Life Sciences investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Intel (INTC) and Netflix (NFLX).

Company Calendar

Last Earnings
5/08/2025
Today
7/11/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:WVE
CIK
1631574
Employees
240
Year Founded
N/A

Price Target and Rating

High Price Target
$36.00
Low Price Target
$10.00
Potential Upside/Downside
+157.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$97.01 million
Net Margins
N/A
Pretax Margin
-107.04%
Return on Equity
-86.49%
Return on Assets
-37.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.95
Quick Ratio
2.95

Sales & Book Value

Annual Sales
$108.30 million
Price / Sales
11.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.37 per share
Price / Book
5.80

Miscellaneous

Outstanding Shares
155,560,000
Free Float
118,259,000
Market Cap
$1.24 billion
Optionable
Optionable
Beta
-1.01

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:WVE) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners